B L 137
Pill imprint B L 137 has been identified as Cephalexin monohydrate 500 mg.
Cephalexin is used in the treatment of bacterial infection; bladder infection; upper respiratory tract infection; skin infection; kidney infections (and more), and belongs to the drug class first generation cephalosporins. There is no proven risk in humans during pregnancy.
Cephalexin 500 mg is not subject to the Controlled Substances Act.
See also related documents.
Cephalexin monohydrate Images
- Imprint:
-
B L
137 - Strength:
- 500 mg
- Color:
- White
- Size:
- 16.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- hypromelloses
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polysorbate 80
sodium starch glycolate type A potato
titanium dioxide
- Drug Class:
- First generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-2240
More Cephalexin Monohydrate resources
- Cephalexin
- Cephalexin (Wolters Kluwer)
- Cephalexin Capsules (Wolters Kluwer)
- Cephalexin Suspension (Wolters Kluwer)
- cephalexin (Cerner Multum)
- Novo-Lexin (Micromedex) - Includes Dosage Information
- Panixine DisperDose (Micromedex) - Includes Dosage Information
- cephalexin (Micromedex) - Includes Dosage Information
- Cephalexin (AHFS DI)
- Cephalexin (FDA)
- Cephalexin Suspension (FDA)
- Cephalexin (Wolters Kluwer)


